Page last updated: 2024-10-23

azathioprine and Secondary Hyperparathyroidism

azathioprine has been researched along with Secondary Hyperparathyroidism in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frederiksen, AM1
Hansen, JM1
Ewers, B1
Gasbjerg, A1
Marckmann, P1
Lobo, PI1
Cortez, MS1
Stevenson, W1
Pruett, TL1

Other Studies

2 other studies available for azathioprine and Secondary Hyperparathyroidism

ArticleYear
[Kidney function and immunosuppression of kidney-transplanted patients].
    Ugeskrift for laeger, 2008, May-05, Volume: 170, Issue:19

    Topics: Adult; Azathioprine; Cross-Sectional Studies; Cyclosporine; Drug Therapy, Combination; Female; Follo

2008
Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol.
    Clinical transplantation, 1995, Volume: 9, Issue:4

    Topics: Adolescent; Adult; Aged; Azathioprine; Calcitriol; Calcium; Child; Child, Preschool; Chronic Kidney

1995